Navigation Links
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Date:1/18/2012

te values and applicable local practices, policies and requirements.

The financial impact of this plan within fiscal 2011 ending March 2012 is estimated at Yen 35 billion downward in income, and the revised forecast of Takeda's consolidated financial statements, including these strategic measures and other factors, will be disclosed upon fiscal 2011 3Q earnings release announcement scheduled on the 1st February 2012. The updates for progress of consolidation of sites and functions will be announced in an appropriate and timely manner.

These strategic measures and plans announced today are subject to appropriate information and consultation processes with affected employees and their representatives in accordance with applicable national laws on a country by country basis, which commence today.

About Takeda

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, http://www.takeda.com.

Takeda's Forward-looking statements

This press release contains forward-looking statements. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on e
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
2. U.S. Food and Drug Administration (FDA) Delays Review of Takedas Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone
3. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
4. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
5. Takeda Completes Acquisition and Names New CEO of Nycomed
6. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
7. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
8. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
9. Takeda to Acquire Nycomed
10. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
11. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than an Oreo ... to self-inject prescription drugs in the large doses required to ... autoimmune deficiencies, and genetic disorders.  An emerging ... 2018, according to analysts.   Many of these drugs will require ...
(Date:1/14/2014)... The Brandeis Medical Center, led by Dr. Emmanuel Brandeis , ... laser tattoo removal experience with the advanced Astanza Duality laser and ... quality cosmetic services with cutting edge medical technology and offering expert ... has seen a dramatic increase in the presence of ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 2011 A new report in the March issue of ... beat brand names when it comes to safety, efficacy, and ... drug programs offering these drugs at prices as low as ... Walgreens, and Walmart have been steadily expanding their discount programs, ...
... JumpStart Ventures , the non-profit that invests in ... Ohio, and Cleveland Clinic , announced a ... Inc. The Cleveland-based company is developing a topical ... formation in wounds. (Logo: http://photos.prnewswire.com/prnh/20060209/CLJUMPSTARTLOGO) ...
Cached Medicine Technology:Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 2Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 3Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 4JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 2JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 3JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 4
(Date:7/9/2014)... researchers have uncovered mutations in a cell-signaling pathway that ... may expand treatments for patients because drugs targeting some ... in clinical trials. , Reporting July 9 in ... including researchers at Washington University School of Medicine in ... tumors from 230 patients with lung adenocarcinoma. , "This ...
(Date:7/9/2014)... a relatively optimistic picture of women,s chances of surviving ... the chest wall or skin, but not beyond. ... size and whether they have involved lymph nodes, are ... advanced" tumors, suggesting that they are a relatively serious ... breast cancers of this and other types account for ...
(Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
(Date:7/9/2014)... personal and subjective, the human brain turns them ... across different senses, situations and even people, reports ... Anderson. , "We discovered that fine-grained patterns of ... of the brain associated with emotional processing, act ... subjective feeling," says Anderson, associate professor of human ...
(Date:7/9/2014)... There has been a sharp increase in the number ... MyChart, the online, interactive service that allows patients to ... providers, schedule appointments, and renew prescriptions. , Over a ... MyChart each year increased five-fold, while the number ... according to a study by Dr. David Gerber ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3
... DavisPTnetwork™, a new social networking Web site, at the APTA ... online physical therapy continuing education courses (contact hours and CEUs), ... ... Philadelphia, PA (PRWEB) March 23, 2009 -- F.A. Davis is ...
... Digital,s unique PC Network software with the advanced SharkNet Duplicator series ... a given network onto a duplicator. , ... Los ... the availability of their latest innovation; the network connectable standalone duplicator ...
... Tuberculosis Day HARRISBURG, Pa., March 23 State Health ... public awareness of tuberculosis, or TB, and the importance ... disease. "In 2008, we saw an increase in the ... more cases resistant to medication, which makes the disease ...
... Nickolas Hooks of Charleston, SC, will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Hooks, 15, is one ... in Kids Speak Up! , a national program ...
... In light of the recent recall of eggs ... safety expert Jeff Nelken is strongly advising Americans, especially ... take precautions when eating eggs at home or in ... potentially one of the most dangerous foods in terms ...
... PEMBROKE, Bermuda, March 23 Darwin National,Assurance Company, ... Ltd (NYSE: AWH ), today announced ... moderate a panel at the PLUS Medical,Symposium held ... The panel, titled "Do,You Know Where Your Tissue/Organ/Medical ...
Cached Medicine News:Health News:New Online Network Features Continuing Education Courses for Physical Therapists 2Health News:Vinpower Digital Introduces the Industry's First Standalone Networkable Duplication Tower 2Health News:Vinpower Digital Introduces the Industry's First Standalone Networkable Duplication Tower 3Health News:Pennsylvania Sees Increase in Tuberculosis, Emphasizing Need for Awareness 2Health News:South Carolina Youth Shares Epilepsy Message on Capitol Hill 2Health News:Food Safety Expert Offers Tips to Be Safe in Wake of Costco & Safeway Egg Recall 2Health News:Darwin to Moderate Panel at Plus Medical Symposium 2Health News:Darwin to Moderate Panel at Plus Medical Symposium 3
... indoor positioning supports patient safety by ... the right patients are in the ... Respond to the exact patient location ... monitor alarms. Measure patient flow times ...
... are preominantly used for routine blood collection. ... of the needle protective cap simplifies visual ... example, yellow symbolises the needle dimension 20 ... mm) and black 22 G (0.70 mm). ...
DiaMed-ID Micro Typing System...
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
Medicine Products: